Condition: Histiocytosis · Histiocytosis, Langerhans-Cell · Histiocytosis Pulmonary · Sponsor: Assistance Publique - Hôpitaux de Paris
The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the long-term outcomes of PLCH patients. This french countrywide registry-based study included a large cohort of PLCH patients followed for a sufficiently long period to address risk factors of long-term outcomes of PLCH patients.
This description comes directly from the study's public registry record.
Abdellatif TAZI, MD PhD · 142499198 · abdellatif.tazi@aphp.fr
matthieu resche-rigon, MD PhD · 142499742 · matthieu.resche-rigon@u-paris.fr
Always discuss trial participation with your own doctor first.
| French national reference centre for Histiocytoses | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04665674